Williams Michael A, Sharkey Phoebe, van Doren Doris, Thomas George, Rigamonti Daniele
Department of Neurology, Johns Hopkins School of Medicine, Maryland, USA.
J Neurosurg. 2007 Jul;107(1):21-8. doi: 10.3171/JNS-07/07/0021.
The goal in this study was to determine the percentage of patients with hydrocephalus who were treated with shunt surgery and to assess Medicare expenditures for those with and without shunt surgery.
Retrospective cost analyses were performed using the Standard Analytic Files of paid claims for beneficiaries enrolled in both Parts A (Inpatient) and B (Outpatient) of the Medicare program for 1997 through 2001. The main outcome measures were 5-year total payments and 5-year payments for separate types of service; for example, acute hospital (inpatient and outpatient), skilled nursing facility, home health, and physician/supplier services.
Of 1441 patients with hydrocephalus, 25.1% underwent shunt surgery during the study period. The effect of a shunt procedure on 5-year Medicare expenditures is a cost difference of $25,477 (p < 0.0001) less per patient, which is equal to a potential -$184.3 million difference in 5-year Medicare expenditures. The following three factors had a negative association with whether shunt surgery was performed: (1) age 80 to 84 years (odds ratio [OR] 0.619, confidence interval [CI] 0.390-0.984); (2) age 85 years or older (OR 0.201, CI 0.110-0.366); and (3) African-American race (OR 0.506, CI 0.295-0.869). The effect of age on the likelihood of shunt surgery persisted after adjusting for the propensity to die score.
Medicare expenditures for patients with hydrocephalus treated with shunt surgery are significantly lower than expenditures for untreated patients. Research to improve the diagnosis and treatment of hydrocephalus has the potential to improve outcomes and reduce health care expenditures further.
本研究的目的是确定接受分流手术治疗的脑积水患者的百分比,并评估接受和未接受分流手术患者的医疗保险支出。
使用1997年至2001年医疗保险计划A部分(住院)和B部分(门诊)参保受益人的付费索赔标准分析文件进行回顾性成本分析。主要结局指标为5年总支付额和各类服务的5年支付额;例如,急性医院(住院和门诊)、熟练护理机构、家庭健康以及医生/供应商服务。
在1441例脑积水患者中,25.1%在研究期间接受了分流手术。分流手术对5年医疗保险支出的影响是每位患者的成本差异减少25477美元(p<0.0001),这相当于5年医疗保险支出潜在相差1.843亿美元。以下三个因素与是否进行分流手术呈负相关:(1)80至84岁(优势比[OR]0.619,置信区间[CI]0.390 - 0.984);(2)85岁及以上(OR 0.201,CI 0.110 - 0.366);(3)非裔美国人种族(OR 0.506,CI 0.295 - 0.869)。在调整死亡倾向评分后,年龄对分流手术可能性的影响仍然存在。
接受分流手术治疗的脑积水患者的医疗保险支出显著低于未治疗患者的支出。改善脑积水诊断和治疗的研究有可能改善治疗效果并进一步降低医疗保健支出。